- Published at
- by manilatimes.net
mixed
mixed
News for GBS Inc. (GBS)
- Published at
- by gurufocus.com
mixedmixedHansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference
PR NewswireLUND, Sweden, Jan. 7, 2025 LUND, Sweden, Jan. 7, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), tod- Published at
- by investing.com
positivepositiveIntuit EVP and CFO Sandeep Aujla sells $68,506 in stock By Investing.com
Intuit EVP and CFO Sandeep Aujla sells $68,506 in stock- Published at
- by investing.com
positivepositiveIntuit's CTO Balazs Alex sells shares worth $15.86 million By Investing.com
Intuit's CTO Balazs Alex sells shares worth $15.86 million- Published at
- by gurufocus.com
neutralneutralHansa Biopharma Completes Enrolment in Global Pivotal Phase 3 Trial of imlifidase in Anti-Glomerular Basement Membrane Disease
PR NewswireLUND, Sweden, Dec. 5, 2024 Data from the trial is expected to be shared in 2025LUND, Sweden, Dec. 5, 2024 /PRNewswire/ -- Hansa Biopharma, "Hans- Published at
- by manilatimes.net
neutralneutral- Published at
- by investing.com
positivepositiveEarnings call: Xerox reports revenue dip, eyes IT services growth By Investing.com
Earnings call: Xerox reports revenue dip, eyes IT services growth- Published at
- by investing.com
mixedmixedEarnings call: GSK reports strong Q3 growth, optimistic for 2024 By Investing.com
Earnings call: GSK reports strong Q3 growth, optimistic for 2024- Published at
- by flipboard.com
positivepositiveEarnings call: Xerox reports revenue dip, eyes IT services growth By Investing.com
Earnings call: Xerox reports revenue dip, eyes IT services growth- Published at
- by investing.com
positivepositive- Published at
- by business-standard.com
mixedmixedStocks to Watch, Aug 27: Medi Assist, Bondada, Paytm, Repro India, Mazagon
Stocks to Watch Today, Aug 27: Bondada Engineering has received a Letter of Award for a project worth Rs 575.74 crore from Lumina Clean Energy, Purelight Energy, and VVKR Photovoltaics Energy- Published at
- by globenewswire.com
mixedmixedCrown LNG Holding AS Announces Completion of Business Combination with Catcha Investment Corp
Combination accelerates Crown LNG’s mission to enable stable, secure, year-round LNG supplies to growing markets and locations exposed to harsh weather...- Published at
- by investing.com
positivepositive- Published at
- by investing.com
positivepositive- Published at
- by investing.com
mixedmixedLegend Biotech's CARVYKTI ® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma By Investing.com
Legend Biotech's CARVYKTI ® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma- Published at
- by globenewswire.com
mixedmixedGBS Inc. Initiates Company Name Change to Intelligent Bio Solutions Inc. (IBSS) and Announces Key Executive Appointments
- Name change to more closely reflect firm’s expanding portfolio of intelligent, efficient, convenient and practical noninvasive and drug testing...- Published at
- by marketscreener.com
mixedmixedMarizyme : Amendment to Quarterly Report (Form 10-Q/A)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A ... | November 22, 2021- Published at
- by rttnews.com
mixedmixedFDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO's REVEAL 1 Meets Goals
Today's Daily Dose brings you news about the regulatory set back of Athenex's oral Paclitaxel and CorMedix's Defencath, ASLAN Pharma's Atopic Dermatitis trial results, FDA panel review of FibroGen's Roxadustat, Morphic Therapeutic's Phase 1 single ascending dose clinical trial of MORF-057, which is in development for the treatment of inflammatory bowel disease, and STRATA Skin's CEO transition.- Published at
- by markets.businessinsider.com
mixedmixedThe Week Ahead In Biotech: FDA To Issue Decisions On Merck And Aurinia Drug Applications
Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in,...- Published at
- by benzinga.com
mixedmixedThe Week Ahead In Biotech: FDA To Issue Decisions On Merck And Aurinia Drug Applications
Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in, with most ...